ImCheck Therapeutics Competitors and Similar CompaniesClear all
ImCheck Therapeutics's competitors and similar companies include MedDay and Carmot Therapeutics.
 ImCheck Therapeutics ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators . |  MedDay MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases. |  Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. | |
Founding Date | Founding Date 2015 | Founding Date 2011 | Founding Date 2008 |
Type | Type Private | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Marseille, FR HQ | Locations Clichy, FR HQ Paris, FR Boston, US | Locations Berkeley, US HQ |
Employees | Employees 57 | Employees 3710% decrease | Employees 109% decrease |
Funding | |||
Latest funding round | Latest funding round $ 53.2m (over 6 years ago) | Latest funding round $ 38.5m (over 10 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 76.1m | Total funding raised $ 48.9m | Total funding raised $ 74.8m |
For sources of this data, please see the company profile
View Company Profiles
MedDay
HQ
Clichy, FR
Employees
37↓ 10% decrease
MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.
View companyCarmot Therapeutics
HQ
Berkeley, US
Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.
View company